The contemporary biopharmaceutical ecosystem is currently navigating a profound systemic productivity crisis, frequently contextualized by "Eroom’s Law," wherein the cost of bringing a single novel therapeutic to market has surged exponentially to between $800 million and $1.4 billion.

It's important to note that while AI offers many potential benefits, it is not a silver bullet. Colleges will need to carefully consider the ethical and practical implications of using AI in admissions and financial aid, and ensure that these technologies are used in a way that is fair, transparent, and equitable.